国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2014年
11期
1496-1497
,共2页
苏正活%钟健清%李翠莲%郑小燕
囌正活%鐘健清%李翠蓮%鄭小燕
소정활%종건청%리취련%정소연
雷贝拉唑%半夏泻心汤%消化性溃疡%联合治疗
雷貝拉唑%半夏瀉心湯%消化性潰瘍%聯閤治療
뢰패랍서%반하사심탕%소화성궤양%연합치료
Rabeprazole%BanxiaxiexinTang%Peptic ulcer%Combination therapy
目的 探讨中药制剂半夏泻心汤联合质子泵抑制剂雷贝拉唑对消化性溃疡治疗的临床疗效.方法 对我院2010年1月至2013年5月收治的78例消化性溃疡患者采取对比治疗的方式,随机分为两组,其中治疗组采用半夏泻心汤联合雷贝拉唑的药物联合治疗方法,对照组则采用单独以雷贝拉唑为基础的药物治疗方法,比较两组的疗效和不良反应发生率.结果 治疗组和对照组的治愈率分别为87.18%和76.92%,总有效率为94.87和87.18%,两组比较差异有统计学意义(P<0.05);治疗组和对照组不良反应发生率分别2.56%和7.69%,治疗组不良反应发生率更低.结论 采用半夏泻心汤联合雷贝拉唑联合治疗消化性溃疡更为确切,不良发生概率更低.
目的 探討中藥製劑半夏瀉心湯聯閤質子泵抑製劑雷貝拉唑對消化性潰瘍治療的臨床療效.方法 對我院2010年1月至2013年5月收治的78例消化性潰瘍患者採取對比治療的方式,隨機分為兩組,其中治療組採用半夏瀉心湯聯閤雷貝拉唑的藥物聯閤治療方法,對照組則採用單獨以雷貝拉唑為基礎的藥物治療方法,比較兩組的療效和不良反應髮生率.結果 治療組和對照組的治愈率分彆為87.18%和76.92%,總有效率為94.87和87.18%,兩組比較差異有統計學意義(P<0.05);治療組和對照組不良反應髮生率分彆2.56%和7.69%,治療組不良反應髮生率更低.結論 採用半夏瀉心湯聯閤雷貝拉唑聯閤治療消化性潰瘍更為確切,不良髮生概率更低.
목적 탐토중약제제반하사심탕연합질자빙억제제뢰패랍서대소화성궤양치료적림상료효.방법 대아원2010년1월지2013년5월수치적78례소화성궤양환자채취대비치료적방식,수궤분위량조,기중치료조채용반하사심탕연합뢰패랍서적약물연합치료방법,대조조칙채용단독이뢰패랍서위기출적약물치료방법,비교량조적료효화불량반응발생솔.결과 치료조화대조조적치유솔분별위87.18%화76.92%,총유효솔위94.87화87.18%,량조비교차이유통계학의의(P<0.05);치료조화대조조불량반응발생솔분별2.56%화7.69%,치료조불량반응발생솔경저.결론 채용반하사심탕연합뢰패랍서연합치료소화성궤양경위학절,불량발생개솔경저.
Objective To explore the clinical efficacy of traditional Chinese medicine preparation BanxiaxiexinTang combined with proton pump inhibitor rabeprazole for the treatment of peptic ulcer.Methods In our hospital from January 2010 to May 2013 78 cases of peptic ulcer patients treated taking treatment modality contrast,were randomly divided into two groups,one treatment group of BanxiaxiexinTang combined with drug rabeprazole combination therapy,the control group used the drug treatment alone,rabeprazole-based,two groups were compared the efficacy and incidence of adverse reactions.Results The cure rates of treatment and control groups were 87.18% and 76.92%,total effective rates were 94.87% and 87.18% respectively,showing statistically significant difference (P < 0.05).The adverse reaction rate of treatment group (2.56%) was much lower than that of control group (7.69%).Conclusion BanxiaxiexinTang combined with rabeprazole has more precise treatment for peptic ulcer,with lower incidence probability of adverse reaction.